# Nausea & Vomiting

Taylor Riggs

---

## Etiology

VOMMIIT mnemonic

- <u>V</u>estibular: Labyrinthitis, vestibular neuritis, meniere’s
    disease, cerebellar stroke

- <u>O</u>bstruction: adhesions, hernia, volvulus, constipation, gastric
    outlet obstruction

- <u>M</u>otility: gastroparesis, GERD, autonomic dysfunction

- <u>M</u>edications: antibiotics, SSRI, opioids, cannabinoid
    hyperemesis

- <u>I</u>nfection: gastroenteritis, hepatitis, pyelonephritis,
    cholecystitis

- <u>I</u>nflammation: PUD, pancreatitis

- <u>T</u>oxins: uremia, ketoacidosis, hypercalcemia, chemotherapy

## Evaluation

- All patients: CBC (leukocytosis, Hgb), BMP (AG, Ca, lytes, AKI),
    LFTs, lipase, lactate, UA

- If risk factors: consider TSH, AM cortisol, troponin, β hCG, UDS

- EKG to eval for ischemia and baseline QTc

- Imaging:
    - If concern for obstruction (abd distention, decreased BMs) KUB,
    consider CT A/P
    - If concern for biliary pathology (RUQ pain, abnl LFTs) RUQ U/S
    - If vestibular/concern for CNS pathology CTH vs MRI brain

# Management

Address underlying cause and stop medications as appropriate

- Many antiemetics prolong QTc, however in patients without underlying
    cardiac conduction abnormality, electrolyte abnormality, or organ
    failure the risk of QTc prolongation leading to significant
    arrhythmia is low.
- Obtain screening EKG in patients with underlying heart disease,
    electrolyte abnormalities, organ failure or on other QTc prolonging
    meds (antiarrhythmics, antipsychotics, antibiotics)
- 4-8 mg of IV Zofran is estimated to prolong QTc by ~6ms
- Try to pick a medication that will address the underlying etiology
    of nausea
- If patient does not respond to a medication in a certain class, try
    a medication from a different class (see below)

<table>
<colgroup>
<col style="width: 22%" />
<col style="width: 27%" />
<col style="width: 32%" />
<col style="width: 17%" />
</colgroup>
<thead>
<tr class="header">
<th colspan="4">Anti-Emetics</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Med (by class)</td>
<td>Typical Dose</td>
<td>Side Effects</td>
<td>Prolongs QT?</td>
</tr>
<tr class="even">
<td colspan="4"><strong>Serotonin antagonists</strong></td>
</tr>
<tr class="odd">
<td>Ondansetron (Zofran)</td>
<td>4-8mg PO/IV q6h</td>
<td>Constipation, headache, arrhythmia, serotonin syndrome</td>
<td>Yes</td>
</tr>
<tr class="even">
<td><p>Granisetron</p>
<p>(Kytril)1</p></td>
<td>1 mg PO BID, 2mg pre-chemo, OR 10mcg/kg IV pre-chemo</td>
<td>‘’</td>
<td>Yes</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>Dopamine Antagonists</strong></td>
</tr>
<tr class="even">
<td>Prochlorperazine (Compazine)</td>
<td>5-10 mg PO/IV q6h, 25 mg PR q6h</td>
<td>EPS, less sedation than H-blockers (e.g. Phenergan)</td>
<td>Yes</td>
</tr>
<tr class="odd">
<td><p>Haloperidol</p>
<p>(Haldol)</p></td>
<td>0.5-1 mg PO/IV q6h</td>
<td>EPS, arrhythmia</td>
<td>Yes</td>
</tr>
<tr class="even">
<td>Zyprexa (Olanzapine)</td>
<td>5 -10mg PO qdaily</td>
<td>EPS, constipation, anticholinergic</td>
<td>Mild ^</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>Dopamine and Serotonin Antagonists</strong></td>
</tr>
<tr class="even">
<td>Metoclopramide (Reglan)</td>
<td>10 mg PO/IV q6h</td>
<td>EPS/dystonia, arrhythmias, drowsiness/dizziness, diarrhea</td>
<td>Yes</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>GABA-A Agonist</strong></td>
</tr>
<tr class="even">
<td><p>Lorazepam</p>
<p>(Ativan)</p></td>
<td>0.5-1mg PO/IV q6h PRN</td>
<td>Sedation, delirium, amnesia, respiratory depression</td>
<td>No</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>H1 Antagonists</strong></td>
</tr>
<tr class="even">
<td>Promethazine (Phenergan)</td>
<td>12.5 - 25mg PO /PR /IV q6h (avoid IV use if possible)</td>
<td>Sedation, EPS (D2 antagonist also), arrhythmias, blurry vision</td>
<td>Yes</td>
</tr>
<tr class="odd">
<td>Diphenhydramine (Benadryl)</td>
<td>25-50mg PO/IV q6h</td>
<td>Sedation, delirium, urinary retention, ileus</td>
<td>Yes</td>
</tr>
<tr class="even">
<td><p>Meclizine</p>
<p>(Antivert)</p></td>
<td>12.5-25mg PO q6h</td>
<td>Sedation, dizziness, falls, blurry vision</td>
<td>Yes</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>Anticholinergics</strong></td>
</tr>
<tr class="even">
<td>Scopolamine</td>
<td>1 mg patch q3day</td>
<td>Dry mouth, blurry vision, drowsiness</td>
<td>No</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>Glucocorticoids</strong></td>
</tr>
<tr class="even">
<td>Dexamethasone</td>
<td>4-8mg PO/IV prior to chemo or XRT, typically use with other
agents</td>
<td>Hyperglycemia, fluid retention, delirium</td>
<td>No</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>NK1 Antagonists</strong></td>
</tr>
<tr class="even">
<td>Aprepitant</td>
<td>Given prior to/with chemo</td>
<td>Fatigue, neutropenia</td>
<td>No</td>
</tr>
<tr class="odd">
<td colspan="4"><strong>CBD Agonists</strong></td>
</tr>
<tr class="even">
<td>Dronabinol</td>
<td>2.5-5mg BID</td>
<td>Dizziness, increased appetite, Tachycardia, hypotension</td>
<td>No</td>
</tr>
</tbody>
</table>
